Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.

Saved in:
Bibliographic Details
Title: Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Authors: Goodall RL; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK. Electronic address: r.goodall@ucl.ac.uk., Meredith SK; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Nunn AJ; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Bayissa A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Bhatnagar AK; Rajan Babu Institute for Pulmonary Medicine & Tuberculosis, Delhi, India., Bronson G; Vital Strategies, New York, NY, USA., Chiang CY; Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; International Union against Tuberculosis and Lung Disease, Paris, France., Conradie F; Empilweni TB Hospital, Eastern Cape, South Africa., Gurumurthy M; Vital Strategies, Singapore., Kirenga B; Makerere University Lung Institute, Mulago Hospital, Kampala, Uganda., Kiria N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Meressa D; St Peter's Tuberculosis Specialized Hospital and Global Health Committee, Addis Ababa, Ethiopia., Moodliar R; Tuberculosis & HIV Investigative, Doris Goodwin Hospital, Pietermaritzburg, South Africa., Narendran G; National Institute for Research in Tuberculosis, Chennai, India., Ngubane N; King Dinuzulu Hospital Complex, Durban, South Africa., Rassool M; Clinical HIV Research Unit, Helen Joseph Hospital, Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa., Sanders K; Medical Research Council Clinical Trials Unit at UCL, University College London, London, UK., Solanki R; B J Medical College, Ahmedabad, India., Squire SB; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK., Torrea G; Institute of Tropical Medicine, Antwerp, Belgium., Tsogt B; Mongolian Tuberculosis Coalition, Ulaanbaatar, Mongolia., Tudor E; Institute of Phthisiopneumology Chiril Draganiuc, Chisinau, Moldova., Van Deun A; Institute of Tropical Medicine, Antwerp, Belgium., Rusen ID; Vital Strategies, New York, NY, USA.
Corporate Authors: STREAM study collaborators
Source: Lancet (London, England) [Lancet] 2022 Nov 26; Vol. 400 (10366), pp. 1858-1868. Date of Electronic Publication: 2022 Nov 08.
Publication Type: Randomized Controlled Trial; Multicenter Study; Journal Article; Equivalence Trial
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-547X
DOI:10.1016/S0140-6736(22)02078-5